NCT06400342: An ongoing trial by Medstar Health Research Institute
This trial is ongoing. It must report results 9 years, 4 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06400342 |
|---|---|
| Title | Randomized Evaluation of Valve-In-Valve Versus Explantation for Failed TAVR (REVIVE-TAVR) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 1, 2025 |
| Completion date | May 1, 2034 |
| Required reporting date | May 1, 2035, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |